期刊文献+

药物性肝损害临床特点及治疗分析 被引量:8

Clinical analysis and treatment of the drug-induced liver injure
原文传递
导出
摘要 目的 探讨药物性肝损害的临床特点及治疗方法.方法 对2000-2008年我院收治的药物性肝损害206例患者的临床资料进行回顾性分析.结果 引起肝损害的药物种类繁多,以抗生素(包括抗结核药物)为最多,占40.3%(83/206),其次为抗肿瘤药,占15.5%(32/206).临床以肝细胞型多见,占49.5%(102/206),胆汁淤积型占29.6%(61/206),混合型占20.9%(43/206).主要临床表现有纳差、乏力、黄疸、上腹部不适、皮疹、发热.实验室检查丙氨酸氨基转移酶升高206例(100.0%);碱性磷酸酶升高108例(52.4%);总胆红素升高54例(26.2%).临床治愈165例,好转32例,自动出院7例,死亡2例.结论 引起药物性肝损害的药物种类很多,应及早发现及时治疗. Objective To analyse the clinical characteristics and the treatment of drug-induced liver injury.Methods Two hundred and six patients with drug-induced liver injury admitted to our hospital from 2000 to 2008 were reviewed retrospectively.Results A variety of drugs were involved in causing liver disease.The common offending agents were antimicrobial agents(40.3%,83/206),and antineoplastic(15.5%,32/206);49.5%(102/206) was classified as hepatocellular type,29.6%(61/206) as cholestatic type,and 20.9%(43/206) as mixed type.The main clinical manifestations were fatigue,jaundice,anorexia,epigastrium uncomfortable,rash,fever.The laboratory tests of liver functions showed increased levels of ALT (100.0%),ALP (52.4%,108/206) and TD(26.2%,54/206).165 patients recovered,32 patients improved,and 2 patients died.Conclusions A variety of drugs can induce liver disease.
机构地区 解放军第一
出处 《中国综合临床》 2010年第4期397-399,共3页 Clinical Medicine of China
关键词 药物性肝损害 抗结核药物 抗肿瘤药物 Drug-induced liver disease Antituberculosis drugs Antineoplastic drugs
  • 相关文献

参考文献5

  • 1许建明.急性药物性肝损伤诊治建议(草案)[J].中华消化杂志,2007,27(11):765-767. 被引量:349
  • 2叶维法.临床肝胆病学[M].天津:天津科学技术出版社,2002:723-724.
  • 3Bénichou C.Criteria of drug-induced liver disorders.Report of an international consensus meeting[J].J Hepatol,1990,11(2):272-276.
  • 4Andrade RJ,Lucena MI,Fernández MC.Drug-induced liver injury:an analysis of 461 incidences submitted to the Spanish registry ovel a 10-year period[J].Gastroenterology,2005,129(2):512-521.
  • 5Meier Y,Cavallaro M,Roos M.Incidence of drug-induced liver injury in medical inpatienta[J].Eur J Clin Pharmacol,2005,61(2):135-143.

二级参考文献16

  • 1Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis, 2002, 22: 145-155.
  • 2Amacher DE. Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol, 1998, 27:119-130.
  • 3Andrade RJ, Lucena MI, Pachkoria K, et al. Chronic liver damage after an episode of idiosyncratic drug induced liver injury (DILI). J Hepatol, 2006, 44(suppl 2):S247.
  • 4Nathwani RA, Kaplowitz N. Drug hepatotoxicity. Clin Liver Dis, 2006, 10:207-217.
  • 5Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol, 1990, 11 : 272-276
  • 6Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf, 2007, 30:277-294.
  • 7Temple R. Hy's law: predicting serious hepatotoxicity. Pharmaco epidemiol Drug Saf, 2006, 15 : 241-243.
  • 8Poison J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology, 2005, 41 : 1179-1197.
  • 9Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med, 2006, 354:731-739.
  • 10Aithal GP, Rawlins MD, Day CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol, 2000, 33:949-952.

共引文献365

同被引文献75

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部